首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >P-015?–?Formulation development of nifedipine controlled-release coated tablets
【24h】

P-015?–?Formulation development of nifedipine controlled-release coated tablets

机译:P-015-?硝苯地平控释包衣片剂的研制[sup>

获取原文
       

摘要

Due to frequent administration of oral nifedipine tablet, controlledor sustained release of the drug will improve patientcompliance, stable blood level and side effect decrement [1,2].Various extended release nifedipine products have been commerciallyavailable. In this study, extended release tabletsof this drug were formulated using sodium alginate,hydroxypropylmethylcellulose (HPMC) as controlled releasematrix materials. Small scale production of 200 tablets andscale-up production to 5000 tablets were performed by manualand electrical single punch tableting machines. The tabletswere then film coated. Physicochemical evaluation wasfollowed USP 32 including assay, content uniformity and impuritiesanalyzed by high performance liquid chromatography.The effect of amount of the polymers and lactose on drugrelease was compared. Moreover, stability study of the selectedformulation was performed at room temperature(25 °C).
机译:由于经常口服硝苯地平片,该药物的控释或缓释可改善患者的依从性,稳定的血药水平和副作用的减少[1,2]。在这项研究中,使用海藻酸钠,羟丙基甲基纤维素(HPMC)作为控释基质材料配制了该药物的缓释片剂。通过手动和电动单冲片机进行小批量生产200片并将规模扩大到5000片。然后将片剂薄膜包衣。按照USP 32标准进行理化评价,包括高效液相色谱法测定,含量均一性和杂质分析。比较了聚合物和乳糖含量对药物释放的影响。此外,在室温(25°C)下对所选配方进行稳定性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号